{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:41:54Z","timestamp":1785901314325,"version":"3.56.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Russian Foundation for Basic Research","award":["13-04-01282-a"],"award-info":[{"award-number":["13-04-01282-a"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jconrel.2016.04.011","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T15:59:09Z","timestamp":1460303949000},"page":"20-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Application of vasoactive and matrix-modifying drugs can improve polyplex delivery to tumors upon intravenous administration"],"prefix":"10.1016","volume":"232","author":[{"given":"Mikhail O.","family":"Durymanov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey V.","family":"Yarutkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry V.","family":"Bagrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry V.","family":"Klinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Kedrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay K.","family":"Chemeris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey A.","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S.","family":"Sobolev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.04.011_bb0005","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpharm.2011.07.013","article-title":"Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies","volume":"427","author":"Wang","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0015","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.addr.2004.12.008","article-title":"Intracellular routing of plasmid DNA during non-viral gene transfer","volume":"57","author":"Lechardeur","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/cr800409e","article-title":"Nonviral vectors for gene delivery","volume":"109","author":"Mintzer","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0025","doi-asserted-by":"crossref","first-page":"10209","DOI":"10.1016\/j.biomaterials.2013.08.076","article-title":"Microdistribution of MC1R-targeted polyplexes in murine melanoma tumor tissue","volume":"34","author":"Durymanov","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.04.011_bb0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1567-5769(02)00271-0","article-title":"Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications","volume":"3","author":"Maeda","year":"2003","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0065-2571(00)00013-3","article-title":"The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting","volume":"41","author":"Maeda","year":"2001","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0040","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/micc.12228","article-title":"A retrospective 30years after discovery of the EPR effect of solid tumors: next-generation chemotherapeutics and photodynamic-therapy-problems, solutions, and prospects","volume":"23","author":"Maeda","year":"2016","journal-title":"Microcirculation"},{"key":"10.1016\/j.jconrel.2016.04.011_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.01.002","article-title":"Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity","volume":"91","author":"Maeda","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-chembioeng-061010-114300","article-title":"Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies","volume":"2","author":"Chauhan","year":"2011","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0060","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.drudis.2006.07.005","article-title":"Exploiting the enhanced permeability and retention effect for tumor targeting","volume":"11","author":"Iyer","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2016.04.011_bb0065","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1073\/pnas.96.6.3137","article-title":"Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules","volume":"96","author":"Netti","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0070","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0360-3016(00)00694-5","article-title":"Changes in tumor oxygenation\/perfusion induced by the no donor, isosorbide dinitrate, in comparison with carbogen: monitoring by EPR and MRI","volume":"48","author":"Jordan","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0075","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.molcel.2010.07.013","article-title":"S-nitrosylation of \u03b2-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability","volume":"39","author":"Thibeault","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2016.04.011_bb0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1349-7006.1994.tb02362.x","article-title":"Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor","volume":"85","author":"Maeda","year":"1994","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0085","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/ncomms3516","article-title":"Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels","volume":"4","author":"Chauhan","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.addr.2011.09.007","article-title":"How to improve exposure of tumor cells to drugs \u2014 promoter drugs increase tumor uptake and penetration of effector drugs","volume":"64","author":"Marcucci","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jconrel.2012.08.027","article-title":"Subcellular trafficking and transfection efficacy of polyethylenimine\u2013polyethylene glycol polyplex nanoparticles with a ligand to melanocortin receptor-1","volume":"163","author":"Durymanov","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.04.011_bb0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jconrel.2015.07.028","article-title":"Live imaging of transgene expression in Cloudman S91 melanoma cells after polyplex-mediated gene delivery","volume":"215","author":"Durymanov","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.04.011_bb0105","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1134\/S0006297913110035","article-title":"Malignant melanoma and melanocortin 1 receptor","volume":"78","author":"Rosenkranz","year":"2013","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.jconrel.2016.04.011_bb0110","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/sj.bjc.6600441","article-title":"Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker","volume":"87","author":"Salazar-Onfray","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2016.04.011_bb0115","first-page":"6352","article-title":"Characterization of receptors for \u03b1-melanocyte-stimulating hormone on human melanoma cells","volume":"49","author":"Siegrist","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/mt.2010.233","article-title":"Properties of PEI-based polyplex nanoparticles that correlate with their transfection efficacy","volume":"19","author":"Ulasov","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1134\/S1607672911020062","article-title":"Investigation of transport and unpacking mechanisms of polyplexes for transfection efficacy on different cell lines","volume":"437","author":"Trusov","year":"2011","journal-title":"Dokl. Biochem. Biophys."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0130","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1054\/bjoc.2001.1809","article-title":"3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon","volume":"84","author":"Konerding","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2016.04.011_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11060-007-9407-2","article-title":"Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats","volume":"85","author":"Stuhr","year":"2007","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0140","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0344-0338(89)80230-4","article-title":"Vascular architecture of melanocytic skin tumors: a quantitative immunohistochemical study using automated image analysis","volume":"185","author":"Smolle","year":"1989","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2016.04.011_bb0150","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0002-9440(10)65006-7","article-title":"Openings between defective endothelial cells explain tumor vessel leakiness","volume":"156","author":"Hashizume","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nm981","article-title":"Two-photon fluorescence correlation microscopy reveals the two-phase nature of transport in tumors","volume":"10","author":"Alexandrakis","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0160","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1158\/0008-5472.CAN-05-2242","article-title":"Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector","volume":"66","author":"McKee","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0165","doi-asserted-by":"crossref","first-page":"18632","DOI":"10.1073\/pnas.1318415110","article-title":"Combining two strategies to improve perfusion and drug delivery in solid tumors","volume":"110","author":"Stylianopoulos","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0170","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/bjc.1992.392","article-title":"Monitoring blood flow to colorectal liver metastases using laser Doppler flowmetry: the effect of angiotensin II","volume":"66","author":"Hemingway","year":"1992","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2016.04.011_bb0175","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/cas.12152","article-title":"The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect","volume":"104","author":"Maeda","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2183\/pjab.88.53","article-title":"Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting","volume":"88","author":"Maeda","year":"2012","journal-title":"Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0185","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/jjco\/hyp074","article-title":"Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors","volume":"39","author":"Nagamitsu","year":"2009","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0969-8051(95)02040-3","article-title":"Effect of induced hypertension with angiotensin II infusion on biodistribution of 111In-labeled monoclonal antibody","volume":"23","author":"Kinuya","year":"1996","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0195","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2010.10.009","article-title":"Angiotensin II-induced hypertension enhanced therapeutic efficacy of liposomal doxorubicin in tumor-bearing mice","volume":"403","author":"Hattori","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2040-2384-2-14","article-title":"Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability","volume":"2","author":"Sarin","year":"2010","journal-title":"J. Angiogenes. Res."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0205","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrc1910","article-title":"The role of nitric oxide in tumour progression","volume":"6","author":"Fukumura","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2016.04.011_bb0210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0215","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/S0006-3495(02)73933-7","article-title":"Diffusion and convection in collagen gels: implications for transport in the tumor interstitium","volume":"83","author":"Ramanujan","year":"2002","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0220","first-page":"2497","article-title":"Role of extracellular matrix assembly in interstitial transport in solid tumors","volume":"60","author":"Netti","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0225","series-title":"Advances in Genetics","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-12-800148-6.00008-0","article-title":"Polymers for nucleic acid transfer\u2014an overview","volume":"vol. 88","author":"Wagner","year":"2014"},{"key":"10.1016\/j.jconrel.2016.04.011_bb0230","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jconrel.2011.09.071","article-title":"Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors","volume":"157","author":"Sirsi","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.04.011_bb0235","doi-asserted-by":"crossref","first-page":"147ra112","DOI":"10.1126\/scitranslmed.3003778","article-title":"Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4","volume":"4","author":"Ren","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0240","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpharm.2013.10.017","article-title":"Targeted gene delivery to glioblastoma using a C-end rule RGERPPR peptide-functionalised polyethylenimine complex","volume":"458","author":"Wang","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0245","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1111\/j.1349-7006.2009.01323.x","article-title":"Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application","volume":"100","author":"Seki","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0250","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1073\/pnas.1018892108","article-title":"Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors","volume":"108","author":"Diop-Frimpong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0255","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00280-009-1136-0","article-title":"Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma","volume":"66","author":"Otake","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0260","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.canlet.2012.10.006","article-title":"Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer","volume":"328","author":"Chen","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2016.04.011_bb0265","doi-asserted-by":"crossref","first-page":"e31384","DOI":"10.1371\/journal.pone.0031384","article-title":"Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGF\u03b2 activation","volume":"7","author":"Arnold","year":"2012","journal-title":"PLoS One"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916301985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916301985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T18:16:17Z","timestamp":1589652977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916301985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":53,"alternative-id":["S0168365916301985"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.04.011","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of vasoactive and matrix-modifying drugs can improve polyplex delivery to tumors upon intravenous administration","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}